Lysophosphatidylserine induces calcium signaling through Ki16425/VPC32183-sensitive GPCR in bone marrow-derived mast cells and in C6 glioma and colon cancer cells

Archives of Pharmacal Research

Volumn 31, Issue 3, 2008, Pages 310-317

  Kim, Kyeok ^a   Kim, Hyo Lim ^a   Lee, Yun Kyung ^a   Han, Mijin ^a   Sacket, Santosh J ^a   Jo, Ji Yeong ^a   Kim, Yu Lee ^a   Im, Dong Soon ^a  

^a Pusan National University   (South Korea)

Author keywords

Calcium; G Protein coupled receptor; LPA1; LPA3; Lysophosphatidic acid; Lysophosphatidylserine

Indexed keywords

1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; 3 (4 (4 ((1 (2 CHLOROPHENYL)ETHOXY)CARBONYL AMINO) 3 METHYL 5 ISOXAZOLYL) BENZYLSULFANYL) PROPANOIC ACID; 3-(4-(4-((1-(2-CHLOROPHENYL)ETHOXY)CARBONYL AMINO)-3-METHYL-5-ISOXAZOLYL) BENZYLSULFANYL) PROPANOIC ACID; ENZYME INHIBITOR; ESTRANE DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ISOXAZOLE DERIVATIVE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; ORGANOPHOSPHATE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROPIONIC ACID DERIVATIVE; PYRIDINE DERIVATIVE; VPC32183;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; CALCIUM SIGNALING; CELL STRAIN HCT116; COLON TUMOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GLIOMA; HUMAN; MALE; MAST CELL; METABOLISM; MOUSE; PATHOLOGY; RAT; TIME;

ANIMALS; BONE MARROW CELLS; CALCIUM SIGNALING; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRENES; GLIOMA; HCT116 CELLS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ISOXAZOLES; LYSOPHOSPHOLIPIDS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; PERTUSSIS TOXIN; PHOSPHORIC ACID ESTERS; PROPIONIC ACIDS; PYRIDINES; PYRROLIDINONES; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; TIME FACTORS; TYPE C PHOSPHOLIPASES;

EID: 46249114382     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1157-x     Document Type: Article

References (39)

1. An, S., Bleu, T., Hallmark, O. G., and Goetzl, E. J., Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem., 273, 7906-7910 (1998a).
2. An, S., Bleu, T., Zheng, Y., and Goetzl, E. J., Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol. Pharmacol., 54, 881-888 (1998b).
3. Bandoh, K., Aoki, J., Hosono, H., Kobayashi, S., Kobayashi, T., Murakami-Murofushi, K., Tsujimoto, M., Arai, H., and Inoue, K., Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem., 274, 27776-27785 (1999).
4. Brinkmann, V. and Lynch, K. R., FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol., 14, 569-575 (2002).
5. 2+ in the U937 monocyte cell line. Arch. Pharm. Res., 29, 657-665 (2006).
6. Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., and Tigyi, G., International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature. Pharmacol. Rev., 54, 265-269 (2002).
7. Fitzgerald, L. R., Dytko, G. M., Sarau, H. M., Mannan, I. J., Ellis, C., Lane, P. A., Tan, K. B., Murdock, P. R., Wilson, S., Bergsma, D. J., Ames, R. S., Foley, J. J., Campbell, D. A., McMillan, L., Evans, N., Elshourbagy, N. A., Minehart, H., and Tsui, P., Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun., 273, 805-810 (2000).
8. 3 receptor. J. Biol. Chem., 278, 11962-11969 (2003).
9. Hla, T., Lee, M. J., Ancellin, N., Paik, J. H., and Kluk, M. J., Lysophospholipids-receptor revelations. Science, 294, 1875-1878 (2001).
10. Ikeda, H., Satoh, H., Yanase, M., Inoue, Y., Tomiya, T., Arai, M., Tejima, K., Nagashima, K., Maekawa, H., Yahagi, N., Yatomi, Y., Sakurada, S., Takuwa, Y., Ogata, I., Kimura, S., and Fujiwara, K., Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology, 124, 459-469 (2003).
11. Im, D. S., Heise, C. E., Harding, M. A., George, S. R., O'Dowd, B. F., Theodorescu, D., and Lynch, K. R., Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol. Pharmacol., 57, 753-759 (2000).
12. 3 in rat hepatoma cells. Kor. J. Physiol. Pharmacol., 6, 139-142 (2002).
13. Im, D. S., Linking Chinese medicine and G-protein-coupled receptors. Trends. Pharmacol. Sci., 24, 2-4 (2003).
14. Im, D. S., Discovery of new G protein-coupled receptors for lipid mediators. J. Lipid Res., 45, 410-418 (2004).
15. Kawamoto, K., Aoki, J., Tanaka, A., Itakura, A., Hosono, H., Arai, H., Kiso, Y., and Matsuda, H., Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J. Immunol., 168, 6412-6419 (2002).
16. Kim, S. J., Jin, M., Lee, E., Moon, T. C., Quan, Z., Yang, J. H., Son, K. H., Kim, K. U., Son, J. K., and Chang, H. W., Effects of methyl gallate on arachidonic acid metabolizing enzymes: Cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. Arch. Pharm. Res., 29, 874-878 (2006).
17. Kotarsky, K., Boketoft, A., Bristulf, J., Nilsson, N.E., Norberg, A., Hansson, S., Sillard, R., Owman, C., Leeb-Lundberg, F. L., and Olde, B., Lysophosphatidic Acid Binds to and Activates Gpr92, a G Protein-Coupled Receptor Highly Expressed in Gastro-Intestinal Lymphocytes. J. Pharmacol. Exp. Ther., 318, 619-628 (2006).
18. 5. J. Biol. Chem., 281, 23589-23597 (2006).
19. 12/13-mediated Rho activation. J. Biol. Chem., 282, 4310-4317 (2007).
20. Lee, M. J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., and Hla, T., Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell, 99, 301-312 (1999).
21. Lee, Y. K. and Im, D. S., Distinct effects of lysophospholipids on membrane potential in C6 glioma cells. J. Appl. Pharmacol., 14, 25-29 (2006).
22. Liliom, K., Guan, Z., Tseng, J. L., Desiderio, D. M., Tigyi, G., and Watsky, M. A., Growth factor-like phospholipids generated after corneal injury. Am. J. Physiol., 274, C1065-C1074 (1998)
23. Lourenssen, S. and Blennerhassett, M. G., Lysophos-phatidylserine potentiates nerve growth factor-induced differentiation of PC12 cells. Neurosci. Lett., 248, 77-80 (1998).
24. Lynch, K. R. and Im, D. S., Life on the edg. Trends Pharmacol. Sci., 20, 473-475 (1999).
25. Milligan, G., G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol., 66, 1-7 (2004).
26. Noguchi, K., Ishii, S., and Shimizu, T., Identification of p2y9/GPR23 as a novel G protein-coupled receptor for Lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem., 278, 25600-25606 (2003).
27. Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., Yagi, M., Sato, M., Suzuki, R., Murooka, H., Sakai, T., Nishitoba, T., Im, D. S., Nochi, H., Tamoto, K., Tomura, H., and Okajima, F., Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol., 64, 994-1005 (2003).
28. Park, K. S., Lee, H. Y., Kim, M. K., Shin, E. H., Jo, S. H., Kim, S. D., Im, D. S., and Bae, Y. S., Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G proteins. Mol. Pharmacol., 69, 1066-1073 (2006).
29. Sato, T., Aoki, J., Nagai, Y., Dohmae, N., Takio, K., Doi, T., Arai, H., and Inoue, K., Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J. Biol. Chem., 272, 2192-2198 (1997).
30. Sugo, T., Tachimoto, H., Chikatsu, T., Murakami, Y., Kikukawa, Y., Sato, S., Kikuchi, K., Nagi, T., Harada, M., Ogi, K., Ebisawa, M., and Mori, M., Identification of a lysophosphatidylserine receptor on mast cells. Biochem. Biophys. Res. Commun., 341, 1078-1087 (2006).
31. Tigyi, G., Dyer, D. L., and Miledi, R., Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Natl. Acad. Sci. U.S.A., 91, 1908-1912 (1994).
32. van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H., Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell, 59, 45-54 (1989).
33. Wei, S. H., Rosen, H., Matheu, M. P., Sanna, M. G., Wang, S. K., Jo, E., Wong, C. H., Parker, I., and Cahalan, M. D., Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol., 6, 1228-1235 (2005).
34. Xiao, Y., Chen, Y., Kennedy, A. W., Belinson, J., and Xu, Y., Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann. NY Acad. Sci., 905, 242-259 (2000).
35. Xu, Y., Casey, G., and Mills, G. B., Effect of lysophospholipids on signaling in the human Jurkat T cell line. J. Cell Physiol., 163, 441-450 (1995a).
36. Xu, Y., Fang, X. J., Casey, G., and Mills, G. B., Lysophos-pholipids activate ovarian and breast cancer cells. Biochem. J., 309 (Pt 3), 933-940 (1995b).
37. 4/p2y9/GPR23 mediates Rho-dependent morphological changes in a rat neuronal cell line. J. Biol. Chem., 282, 5814-5824 (2007).
38. Yun, M. R., Okajima, F., and Im, D. S., The action mode of lysophosphatidylcholine in human monocytes. J. Pharmacol. Sci., 94, 45-50 (2004).
39. Zaslavsky, A., Singh, L. S., Tan, H., Ding, H., Liang, Z., and Xu, Y., Homo-and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4. Biochim. Biophys. Acta., 1761, 1200-1212 (2006).